GRACE :: Global Resource for Advancing Cancer Education

Recent Post Comments

Share

    • Hi Linnea Great to see you back and looking good! great video too, we need more of the same as it gives others such encouragement best wishes Lesley (More)
    • have at least one of the following high-risk features: ER-negative status, high grade, or young age (less than 35 years of age). Hopefully, women with HER2-positive tumors less than 1 cm will continue to be included in adjuvant trials of HER2-targeted therapy, giving us further data to use to make m (More)
    • I don't think I've ever been to a doctor who didn't ask me if I smoked (I quit 30 years ago), but no one has asked about environmental exposure, even though my address tells anyone that I live very close to a coal-contaminated port, in a city with a lot of lung disease among its inhabitants. Our por (More)
    • I'm sorry I can't answer your question. As a website addressing known cancer diagnoses, we can help address treatment considerations for an esstablished Pancoast tumor but not how to diagnose something that is being worked up but isn't appearing on imaging as a Pancoast tumor. It sounds as if a d (More)
    • I am a 32 yo f with a 15pack year history. I have been having shoulder pain for about 9mths now. Dr #1 did a neck xray and MRI and ruled out pinched nerves and any abnormality in that area. His next suggestion was to do a brain scan. (It seemed strange since he never did any imaging of my shoulder.) (More)
    • That's beautiful. Thank you Dr. Weiss and Thank you Tomma. (More)
    • yniloc, This post was a discussion of the general approaches most commonly employed. It may be helpful to have him see a palliative care specialist about cancer-related symptoms, as they are often among the most proactive people with regard to these issues. Good luck. -Dr. West (More)
    • He also is diabetic, has hypertension, and is 71 years old. They have put him additionally on warfarin. (More)
    • My father has had lung cancer and recently got all of his right side removed. The reason we found the cancer is by chance, after he got admitted to the ER for liver inflammation, they caught the cancer in an Xray. His problem is that from the time that they caught the cancer (back in August) till no (More)
    • I saw it the first time around on live stream and became an immediate bigger fan of this hopeful insight man. Craig your message will find many. We're only beginning to get an idea of what can be done with social media and you're an invaluable pioneer. Best best hopes, Janine (More)
    • Hi Craig, great job! Nice to meet you-sort of! LOL! Take care, Judy (More)
    • We think of a once every 3 week cycle as equiivalent to 3 doses of lower dose weekly therapy. There's no data to say that giving more than an initial 6 weeks of therapy is better than the 2 courses/6 weeks. Many docs favor giving 4 cycles because we know that many patients will have recurrent cancer (More)
    • These are proteins on the cell that help clarify tht the cancer is a lung adenocarcinoma and didn't originate from some different part of the body and isn't a squamous lung cancer. Sounds like you've achieved about as much of a consensus as is possible when there's more than one "right" answer. (More)
    • Would you recommend 4 sessions of chemo (cisplatin and premetrexed) given 1 day, every 3rd week, for 4 weeks? or recommend a different "system" of giving the therapy? You mention "weeks" of therapy. So if given one treatment, and the next one is 3 wks later...is two treatments considered 6 weeks (More)
    • Thanks Dr. West for your video....I'm 1B, in 7th week after a right thoracotomy and right lobectomy. Mine was 4.3 at the largest point. T2a, NO. 63 yrs old. FEV 1 43% pre-bronch, 50% after. Poorly differentiated. Chemo recommend, with cisplatin and pemetrexed (Almita) as you recommend by two onc (More)
    • Immunotherapy is really only available in the form of clinical trials for lung cancer. There is no clearly established benefit of immunotherapy for lung cancer at this time, so it is not a commercially available option for lung cancer anywhere in the world at this time. Good luck. -Dr. West (More)
    • Well understood Doc, My last question, could I discuss with her doctor about immunotheraphy ? Presently She is treated in Indonesia and Singapore Hospital. Is the immunotheraphy worldwidely implemented ? or it is limited by your team investigational only Doc ? Thank you very much Doc. Rega (More)
    • I'm sorry, but I provide general information to help people make decisions with their doctors. I can't provide specific commentary on everyone's individual case, nor can I answer multiple broad questions that don't have clear answers because they're abstract questions. There is no best therapy here, (More)
    • How about Immunotheraphy Doc, I saw your discussion with your colleagues in this site about it, Is it better treatment for lung cancer ? What is the methode of immunotheraphy ? is it injection ? Is that any succeed story about lung cancer ? meaning there is survivor from this disease. based on your (More)
    • The numbers are averages with major variability within the patient populations. There is absolutely no reason to expect that 24 months will be the limit of what to expect. Rash is a general predictor of response and benefit, but it is neither necessary nor sufficient to see benefit. The timin (More)

Ask Us, Q&A
Share

Lung Cancer Awareness Month Information

 


GRACE Website Rebuild

Share

Acquired Resistance Forum Videos

 

ALK+ Lung Cancer Patient Forum Videos

Share

Join the GRACE Faculty

Lung/Thoracic Cancer Blog
Breast Cancer Blog
Pancreatic Cancer Blog
Kidney Cancer Blog
Bladder Cancer Blog
Head/Neck Cancer Blog
Share

Subscribe to the GRACEcast Podcast on iTunes

Share

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon

Subscribe to
GRACE Notes
   (Free Newsletter)

Other Resources

Share

ClinicalTrials.gov


Biomedical Learning Institute

PeerView Press - Curriculum-Based Learning Activities